PANAVAX Trademark

Trademark Overview

On Wednesday, November 24, 2010, a trademark application was filed for PANAVAX with the United States Patent and Trademark Office. The USPTO has given the PANAVAX trademark a serial number of 85184872. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 26, 2018. This trademark is owned by Sanofi Pasteur. The PANAVAX trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine against flu
panavax

General Information

Serial Number85184872
Word MarkPANAVAX
Filing DateWednesday, November 24, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 26, 2018
Registration Number4113833
Registration DateTuesday, March 20, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2012

Trademark Statements

Goods and ServicesHuman vaccine against flu

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi Pasteur
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon 69007
FR
Party NameSanofi Pasteur
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLyon 69007
FR
Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events

Event DateEvent Description
Friday, October 26, 2018CANCELLED SEC. 8 (6-YR)
Monday, March 20, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 7, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 20, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, January 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 1, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 28, 2011ASSIGNED TO LIE
Thursday, November 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, November 3, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, November 3, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, October 21, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 21, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, September 25, 2011NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, September 25, 2011LETTER OF SUSPENSION E-MAILED
Sunday, September 25, 2011SUSPENSION LETTER WRITTEN
Wednesday, September 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 10, 2011NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, March 10, 2011PRIORITY ACTION E-MAILED
Thursday, March 10, 2011PRIORITY ACTION WRITTEN
Thursday, March 3, 2011ASSIGNED TO EXAMINER
Tuesday, November 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 27, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

panavax against vaccine human